Login
$RCKT
$2.19 +$0.03 (1.39%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Gaurav Shah Also a director
Chief Executive Officer and Director
51 Not stated Not stated $3,510,241
Martin Wilson
General Counsel and Chief Corporate Officer, Senior Vice President, Interim Principal Financial Officer
49 Not stated 2021 $3,397,880
Christopher Stevens
Chief Operating Officer
46 Since 2025
1 year
2025 $3,555,467
Syed Rizvi
Chief Medical Officer
59 Since 2025
1 year
2025 Not reported
Jonathan Schwartz
Chief Science & Gene Therapy Officer
62 Not stated 2016 Not reported
Joseph Manhede
Principal Accounting Officer
Title from the Form 8-K dated Jul 8, 2026
Not stated Not stated Not stated Not reported
Sarbani Chaudhuri
See Remarks
Title from the Form 4 dated Nov 9, 2026
51 Not stated 2025 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
6 of 9
stated in the proxy
Average tenure
6.4 years
from year joined
CEO also chairs the board
No
Roderick Wong and Peter Fong
Director Age On board Independent Committees Other public boards 2025 pay Source
Roderick Wong
49 2018
8 years
Not independent None stated Avidity Biosciences, Inc., Landos Biopharma, Inc. $134,898
Peter Fong
52 2025
1 year
Independent None stated None stated $191,385
Gaurav Shah
51 2018
8 years
Not independent None stated Talaris Therapeutics, Inc. Paid as CEO
Carsten Boess
59 2016
10 years
Independent
Audit Committee · Chair
Avidity Biosciences, Inc., Achilles Therapeutics plc $158,025
Mikael Dolsten
68 2024
2 years
Not independent None stated Agilent Technologies, Inc. Not stated
Fady Malik
62 2022
4 years
Independent None stated None stated Not stated
David P. Southwell
65 2014
12 years
Independent None stated PTC Therapeutics Inc. $138,650
Elisabeth Björk Leaving at the meeting
Not stated Not stated Independent None stated None stated Not stated
Piratip Pratumsuwan Leaving at the meeting
Not stated Not stated Independent None stated None stated $627,714

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 6, 2026
Dr. Dolsten
a member of the Board
$125,000 paid in equal monthly installments and $125,000 of RSUs
2025

Consulting agreement with Dr. Dolsten for research and development services, effective March 3, 2025, terminated December 31, 2025; compensation of cash paid in monthly installments and RSUs that cliff vested December 31, 2025.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support